Business

Grant Award

Grant Award.

articleImmupharma PlcNovember 12, 20084/company/immupharma-plc/news/grant-award-3
Grant Award

About this update from Immupharma Plc

[{"type":"text","content":"\n RNS Number : 9464H Immupharma PLC 12 November 2008  \n \nFor Immediate Release                                                                                     12 November 2008\n\n\nImmuPharma awarded grant for developing cancer drug\n\n\nImmuPharma PLC (LSE:IMM), ('ImmuPharma or the 'Company') the specialist drug discovery and development company, is pleased to announce that it has been awarded €0.9m as one of the two grants it has been anticipating from French government organisations. The grants are to be used for the development of ImmuPharma's cancer drug candidate IPP-204106. \n\n\nDr. Robert Zimmer, President & Chief Scientific Officer said: \n'We are both delighted and honoured to have been chosen for the grant by this prestigious French government organisation. Together with the company's internal resources, this grant will fund the development of our exciting cancer compound to the completion of Phase I trials, which we expect to start during 2009.'\n\nFor further information please contact: \n\nImmuPharma PLC: \nDimitri Dimitriou, Chief Executive Officer                                                 +44 20 7152 4080\nRichard Warr, Chairman                                                                        +44 20 7152 4080\nDr Robert Zimmer, President & C...

More updates from Immupharma Plc